Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS Genet ; 17(9): e1009714, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34473702

RESUMEN

The spatio-temporal program of genome replication across eukaryotes is thought to be driven both by the uneven loading of pre-replication complexes (pre-RCs) across the genome at the onset of S-phase, and by differences in the timing of activation of these complexes during S phase. To determine the degree to which distribution of pre-RC loading alone could account for chromosomal replication patterns, we mapped the binding sites of the Mcm2-7 helicase complex (MCM) in budding yeast, fission yeast, mouse and humans. We observed similar individual MCM double-hexamer (DH) footprints across the species, but notable differences in their distribution: Footprints in budding yeast were more sharply focused compared to the other three organisms, consistent with the relative sequence specificity of replication origins in S. cerevisiae. Nonetheless, with some clear exceptions, most notably the inactive X-chromosome, much of the fluctuation in replication timing along the chromosomes in all four organisms reflected uneven chromosomal distribution of pre-replication complexes.


Asunto(s)
Cromosomas Fúngicos , Cromosomas Humanos , Replicación del ADN/genética , Genoma Fúngico , Proteínas de Mantenimiento de Minicromosoma/genética , Saccharomyces cerevisiae/genética , Humanos
2.
Molecules ; 25(3)2020 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-31973227

RESUMEN

Genetic ablation as well as pharmacological inhibition of sirtuin 2 (SIRT2), an NAD+-dependent protein deacylase, have therapeutic effects in various cancers and neurodegenerative diseases. Previously, we described the discovery of a dual SIRT1/SIRT2 inhibitor called cambinol (IC50 56 and 59 µM, respectively), which showed cytotoxic activity against cancer cells in vitro and a marked anti-proliferative effect in a Burkitt lymphoma mouse xenograft model. A number of recent studies have shown a protective effect of SIRT1 and SIRT3 in neurodegenerative and metabolic diseases as well as in certain cancers prompting us to initiate a medicinal chemistry effort to develop cambinol-based SIRT2-specific inhibitors devoid of SIRT1 or SIRT3 modulating activity. Here we describe potent cambinol-based SIRT2 inhibitors, several of which show potency of ~600 nM with >300 to >800-fold selectivity over SIRT1 and 3, respectively. In vitro, these inhibitors are found to be toxic to lymphoma and epithelial cancer cell lines. In particular, compounds 55 (IC50 SIRT2 0.25 µM and <25% inhibition at 50 µM against SIRT1 and SIRT3) and 56 (IC50 SIRT2 0.78 µM and <25% inhibition at 50 µM against SIRT1 and SIRT3) showed apoptotic as well as strong anti-proliferative properties against B-cell lymphoma cells.


Asunto(s)
Antineoplásicos/uso terapéutico , Descubrimiento de Drogas , Linfoma de Células B/tratamiento farmacológico , Sirtuina 2/antagonistas & inhibidores , Acetilación , Animales , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/farmacología , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Ratones , Sirtuina 2/metabolismo , Relación Estructura-Actividad , Tubulina (Proteína)/metabolismo
3.
Epigenetics Chromatin ; 11(1): 50, 2018 08 31.
Artículo en Inglés | MEDLINE | ID: mdl-30170615

RESUMEN

BACKGROUND: The long noncoding RNA Xist is critical for initiation and establishment of X-chromosome inactivation during embryogenesis in mammals, but it is unclear whether its continued expression is required for maintaining X-inactivation in vivo. RESULTS: By using an inactive X-chromosome-linked MeCP2-GFP reporter, which allowed us to enumerate reactivation events in the mouse brain even when they occur in very few cells, we found that deletion of Xist in the brain after establishment of X-chromosome inactivation leads to reactivation in 2-5% of neurons and in a smaller fraction of astrocytes. In contrast to global loss of both H3 lysine 27 trimethylation (H3K27m3) and histone H2A lysine 119 monoubiquitylation (H2AK119ub1) we observed upon Xist deletion, alterations in CpG methylation were subtle, and this was mirrored by only minor alterations in X-chromosome-wide gene expression levels, with highly expressed genes more prone to both derepression and demethylation compared to genes with low expression level. CONCLUSION: Our results demonstrate that Xist plays a role in the maintenance of histone repressive marks, DNA methylation and transcriptional repression on the inactive X-chromosome, but that partial loss of X-dosage compensation in the absence of Xist in the brain is well tolerated.


Asunto(s)
Encéfalo/metabolismo , Represión Epigenética , ARN Largo no Codificante/genética , Inactivación del Cromosoma X , Animales , Metilación de ADN , Código de Histonas , Ratones , Ratones Endogámicos C57BL , ARN Largo no Codificante/metabolismo , Eliminación de Secuencia
4.
J Vis Exp ; (133)2018 03 02.
Artículo en Inglés | MEDLINE | ID: mdl-29553562

RESUMEN

Forward genetic screens using reporter genes inserted into the heterochromatin have been extensively used to investigate mechanisms of epigenetic control in model organisms. Technologies including short hairpin RNAs (shRNAs) and clustered regularly interspaced short palindromic repeats (CRISPR) have enabled such screens in diploid mammalian cells. Here we describe a large-scale shRNA screen for regulators of X-chromosome inactivation (XCI), using a murine cell line with firefly luciferase and hygromycin resistance genes knocked in at the C-terminus of the methyl CpG binding protein 2 (MeCP2) gene on the inactive X-chromosome (Xi). Reactivation of the construct in the reporter cell line conferred survival advantage under hygromycin B selection, enabling us to screen a large shRNA library and identify hairpins that reactivated the reporter by measuring their post-selection enrichment using next-generation sequencing. The enriched hairpins were then individually validated by testing their ability to activate the luciferase reporter on Xi.


Asunto(s)
Proteína 2 de Unión a Metil-CpG/genética , ARN Interferente Pequeño/genética , Inactivación del Cromosoma X/genética , Animales , Femenino , Humanos , Proteína 2 de Unión a Metil-CpG/metabolismo , Ratones
5.
Proc Natl Acad Sci U S A ; 114(7): 1619-1624, 2017 02 14.
Artículo en Inglés | MEDLINE | ID: mdl-28143937

RESUMEN

Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeCP2 on the X chromosome. Because restoration of MeCP2 expression in a mouse model reverses neurologic deficits in adult animals, reactivation of the wild-type copy of MeCP2 on the inactive X chromosome (Xi) presents a therapeutic opportunity in RS. To identify genes involved in MeCP2 silencing, we screened a library of 60,000 shRNAs using a cell line with a MeCP2 reporter on the Xi and found 30 genes clustered in seven functional groups. More than half encoded proteins with known enzymatic activity, and six were members of the bone morphogenetic protein (BMP)/TGF-ß pathway. shRNAs directed against each of these six genes down-regulated X-inactive specific transcript (XIST), a key player in X-chromosome inactivation that encodes an RNA that coats the silent X chromosome, and modulation of regulators of this pathway both in cell culture and in mice demonstrated robust regulation of XIST. Moreover, we show that Rnf12, an X-encoded ubiquitin ligase important for initiation of X-chromosome inactivation and XIST transcription in ES cells, also plays a role in maintenance of the inactive state through regulation of BMP/TGF-ß signaling. Our results identify pharmacologically suitable targets for reactivation of MeCP2 on the Xi and a genetic circuitry that maintains XIST expression and X-chromosome inactivation in differentiated cells.


Asunto(s)
Proteína Morfogenética Ósea 2/genética , Proteína 2 de Unión a Metil-CpG/genética , ARN Largo no Codificante/genética , Factor de Crecimiento Transformador beta/genética , Inactivación del Cromosoma X , Animales , Línea Celular , Femenino , Perfilación de la Expresión Génica , Biblioteca de Genes , Humanos , Ratones , ARN Interferente Pequeño/genética , Síndrome de Rett/genética , Transducción de Señal/genética , Ubiquitina-Proteína Ligasas/genética
8.
J Med Chem ; 57(8): 3283-94, 2014 Apr 24.
Artículo en Inglés | MEDLINE | ID: mdl-24697269

RESUMEN

Sirtuins are a family of NAD(+)-dependent protein deacetylases that play critical roles in epigenetic regulation, stress responses, and cellular aging in eukaryotic cells. In an effort to identify small molecule inhibitors of sirtuins for potential use as chemotherapeutics as well as tools to modulate sirtuin activity, we previously identified a nonselective sirtuin inhibitor called cambinol (IC50 ≈ 50 µM for SIRT1 and SIRT2) with in vitro and in vivo antilymphoma activity. In the current study, we used saturation transfer difference (STD) NMR experiments with recombinant SIRT1 and 20 to map parts of the inhibitor that interacted with the protein. Our ongoing efforts to optimize cambinol analogues for potency and selectivity have resulted in the identification of isoform selective analogues: 17 with >7.8-fold selectivity for SIRT1, 24 with >15.4-fold selectivity for SIRT2, and 8 with 6.8- and 5.3-fold selectivity for SIRT3 versus SIRT1 and SIRT2, respectively. In vitro cytotoxicity studies with these compounds as well as EX527, a potent and selective SIRT1 inhibitor, suggest that antilymphoma activity of this compound class may be predominantly due to SIRT2 inhibition.


Asunto(s)
Antineoplásicos/síntesis química , Isoxazoles/síntesis química , Naftalenos/farmacología , Pirazolonas/síntesis química , Pirimidinonas/farmacología , Sirtuinas/antagonistas & inhibidores , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Descubrimiento de Drogas , Isoxazoles/farmacología , Espectroscopía de Resonancia Magnética , Pirazolonas/farmacología , Relación Estructura-Actividad
9.
Drug Discov Today Dis Mech ; 9(1-2): e29-e33, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23795205

RESUMEN

Our studies indicate that expression of antioxidative stress enzymes is upregulated by Selective Estrogen Receptor Modulators (SERMs) in breast epithelial cell lines, providing protection against the genotoxic effects of estrogens and against estrogen-induced mammary tumorigenesis. This upregulation of antioxidative stress enzymes requires Estrogen Receptor beta (ERß) and human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2). Further studies indicate that hPMC2 has a functional exonuclease domain that is required for upregulation of antioxidative stress enzymes by SERMs and repair of estrogen-induced abasic sites.

10.
Mol Cell Biol ; 31(14): 2920-33, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21606200

RESUMEN

Cell polarity plays a critical role in the development of all metazoans; however, the mechanisms of cell polarity and the specific role of cell polarity pathways in mammalian organisms are still poorly understood. Lethal giant larvae (Lgl) is an apical-basal polarity gene identified in Drosophila, where it functions as a tumor suppressor controlling self-renewal and differentiation of progenitor cells. There are two orthologs of Lgl in mammalian genomes: Llgl1 and Llgl2. While mammalian Lgls are assumed to be tumor suppressor genes, little is known about their function in vivo. Here we report the functional analysis of murine Llgl2. We generated Llgl2(-/-) mice and found that Llgl2 functions as a polarity protein required for proper branching morphogenesis during placental development. Llgl2(-/-) pups are born as runts but quickly catch up in size and grow into normal-size adults. Surprisingly, no prominent phenotypes or spontaneous tumors were observed in adult Llgl2(-/-) mice. Analyses of placental trophoblasts reveal a critical role for Llgl2 in cell polarization and polarized cell invasion. We conclude that mammalian Llgl2 is required for proper polarized invasion of trophoblasts and efficient branching morphogenesis during placental development, but, unlike its Drosophila ortholog, it does not function as a canonical tumor suppressor gene.


Asunto(s)
Proteínas de Homeodominio/metabolismo , Morfogénesis , Placenta/anatomía & histología , Placentación , Isoformas de Proteínas/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Animales , Animales Recién Nacidos/anatomía & histología , Animales Recién Nacidos/fisiología , Moléculas de Adhesión Celular/metabolismo , Proteínas del Citoesqueleto , Embrión de Mamíferos/anatomía & histología , Embrión de Mamíferos/fisiología , Femenino , Regulación del Desarrollo de la Expresión Génica , Genes Supresores de Tumor , Proteínas de Homeodominio/genética , Ratones , Ratones Noqueados , Fenotipo , Embarazo , Isoformas de Proteínas/genética , Proteínas Supresoras de Tumor/genética
11.
Mol Cell Biol ; 26(22): 8623-38, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16954381

RESUMEN

KAP1/TIF1beta is proposed to be a universal corepressor protein for the KRAB zinc finger protein (KRAB-zfp) superfamily of transcriptional repressors. To characterize the role of KAP1 and KAP1-interacting proteins in transcriptional repression, we investigated the regulation of stably integrated reporter transgenes by hormone-responsive KRAB and KAP1 repressor proteins. Here, we demonstrate that depletion of endogenous KAP1 levels by small interfering RNA (siRNA) significantly inhibited KRAB-mediated transcriptional repression of a chromatin template. Similarly, reduction in cellular levels of HP1alpha/beta/gamma and SETDB1 by siRNA attenuated KRAB-KAP1 repression. We also found that direct tethering of KAP1 to DNA was sufficient to repress transcription of an integrated transgene. This activity is absolutely dependent upon the interaction of KAP1 with HP1 and on an intact PHD finger and bromodomain of KAP1, suggesting that these domains function cooperatively in transcriptional corepression. The achievement of the repressed state by wild-type KAP1 involves decreased recruitment of RNA polymerase II, reduced levels of histone H3 K9 acetylation and H3K4 methylation, an increase in histone occupancy, enrichment of trimethyl histone H3K9, H3K36, and histone H4K20, and HP1 deposition at proximal regulatory sequences of the transgene. A KAP1 protein containing a mutation of the HP1 binding domain failed to induce any change in the histone modifications associated with DNA sequences of the transgene, implying that HP1-directed nuclear compartmentalization is required for transcriptional repression by the KRAB/KAP1 repression complex. The combination of these data suggests that KAP1 functions to coordinate activities that dynamically regulate changes in histone modifications and deposition of HP1 to establish a de novo microenvironment of heterochromatin, which is required for repression of gene transcription by KRAB-zfps.


Asunto(s)
Proteínas de Unión al ADN/genética , Heterocromatina/metabolismo , Integrasas/genética , Proteínas Represoras/genética , Transcripción Genética , Línea Celular , Cromatina/metabolismo , Homólogo de la Proteína Chromobox 5 , Proteínas de Unión al ADN/fisiología , Genes Reporteros , Heterocromatina/genética , N-Metiltransferasa de Histona-Lisina , Histonas/metabolismo , Hormonas/farmacología , Humanos , Integrasas/metabolismo , Proteína Metiltransferasas/genética , ARN Polimerasa II/metabolismo , ARN Interferente Pequeño , Proteínas Represoras/fisiología , Proteínas de Saccharomyces cerevisiae/genética , Factores de Transcripción/genética , Transfección , Proteína 28 que Contiene Motivos Tripartito
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA